Shares of FIGS, Inc. (NYSE:FIGS – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eleven analysts that are covering the company, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $18.7143.
A number of analysts have recently weighed in on the stock. Telsey Advisory Group dropped their target price on shares of FIGS from $17.00 to $16.00 and set a “market perform” rating for the company in a report on Friday, August 7th. KeyCorp increased their price objective on FIGS from $19.00 to $20.00 and gave the stock an “overweight” rating in a report on Friday, August 7th. The Goldman Sachs Group restated a “neutral” rating and set a $16.00 target price on shares of FIGS in a report on Friday, August 7th. BTIG Research lifted their price target on shares of FIGS from $20.00 to $22.00 and gave the company a “buy” rating in a report on Friday, August 7th. Finally, Barclays upped their price objective on shares of FIGS from $17.00 to $20.00 and gave the stock an “overweight” rating in a report on Friday, August 7th.
View Our Latest Analysis on FIGS
Institutional Trading of FIGS
FIGS Stock Performance
NYSE:FIGS opened at $13.30 on Friday. FIGS has a fifty-two week low of $6.50 and a fifty-two week high of $17.48. The business has a 50 day moving average price of $12.61 and a 200-day moving average price of $13.19. The firm has a market cap of $2.21 billion, a PE ratio of 40.32 and a beta of 1.07.
FIGS (NYSE:FIGS – Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.08. The business had revenue of $196.62 million during the quarter, compared to analysts’ expectations of $186.17 million. FIGS had a net margin of 8.72% and a return on equity of 12.53%. The firm’s revenue for the quarter was up 28.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.04 EPS. Research analysts predict that FIGS will post 0.32 EPS for the current year.
About FIGS
FIGS, Inc is a direct-to-consumer healthcare apparel and lifestyle company that designs and sells clothing, footwear and accessories for healthcare professionals. Its product portfolio includes medical scrubs, scrub jackets, lab coats, underscrubs, outerwear, shoes, bags and other work-related accessories.
The company markets its products through its digital platform, retail locations and selected wholesale channels. FIGS emphasizes technical fabrics, comfort, functionality and contemporary styling, seeking to provide alternatives to traditional medical uniforms for nurses, physicians and other healthcare workers.
FIGS was founded in 2013 by Heather Hasson and Trina Spear and is headquartered in Santa Monica, California.
See Also
- Five stocks we like better than FIGS
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for FIGS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FIGS and related companies with MarketBeat.com's FREE daily email newsletter.
